ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer

BACKGROUND: Several clinical trials have compared chemotherapy alone and chemoradiotherapy (CRT) for locally advanced pancreatic cancer (LAPC) treatment. However, predictive biomarkers for optimal therapy of LAPC remain to be identified. We retrospectively estimated amplification of the ACTN4 gene t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Watanabe, T, Ueno, H, Watabe, Y, Hiraoka, N, Morizane, C, Itami, J, Okusaka, T, Miura, N, Kakizaki, T, Kakuya, T, Kamita, M, Tsuchida, A, Nagakawa, Y, Wilber, H, Yamada, T, Honda, K
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333489/
https://ncbi.nlm.nih.gov/pubmed/25602965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.623
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars